TY - JOUR AU - Kuban, D. A. AU - Tucker, S. L. AU - Dong, L. PY - 2008 DA - 2008// TI - Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer JO - Int J Radiat Oncol Biol Phys VL - 70 UR - https://doi.org/10.1016/j.ijrobp.2007.06.054 DO - 10.1016/j.ijrobp.2007.06.054 ID - Kuban2008 ER - TY - STD TI - EAU guidelines http://www.uroweb.org/guidelines/online-guidelines/. Accessed 25 June 2014. UR - http://www.uroweb.org/guidelines/online-guidelines/ ID - ref2 ER - TY - JOUR AU - Bolla, M. AU - Poppel, H. AU - Collette, L. PY - 2005 DA - 2005// TI - Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial, 22911) JO - Lancet VL - 366 UR - https://doi.org/10.1016/S0140-6736(05)67101-2 DO - 10.1016/S0140-6736(05)67101-2 ID - Bolla2005 ER - TY - JOUR AU - Langhe, S. PY - 2013 DA - 2013// TI - Acute radiation-induced nocturia in prostate cancer patients is associated with pretreatment symptoms, radical prostatectomy, and genetic markers in the TGFb1 gene JO - Int J Radiat Oncol Biol Phys VL - 85 UR - https://doi.org/10.1016/j.ijrobp.2012.02.061 DO - 10.1016/j.ijrobp.2012.02.061 ID - Langhe2013 ER - TY - JOUR AU - GDe Meerleer, L. AU - Vakaet, S. PY - 2004 DA - 2004// TI - Meersschout et al. Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients JO - Phys VL - 60 ID - GDe Meerleer2004 ER - TY - JOUR AU - Matthias, O. PY - 2014 DA - 2014// TI - Nocturia: state of the art and critical analysis of current assessment and treatment strategies JO - World J Urol VL - 32 UR - https://doi.org/10.1007/s00345-014-1396-0 DO - 10.1007/s00345-014-1396-0 ID - Matthias2014 ER - TY - JOUR AU - Bliwise, D. L. AU - Rosen, R. C. AU - Baum, N. PY - 2014 DA - 2014// TI - Impact of nocturia on sleep and quality of life: a brief, selected review for the international consultation on incontinence research society (ICI-RS) nocturia think tank JO - Neurourol Urodyn VL - 33 UR - https://doi.org/10.1002/nau.22585 DO - 10.1002/nau.22585 ID - Bliwise2014 ER - TY - JOUR AU - Giberti, C. AU - Gallo, F. AU - Cortese, P. AU - Schenone, M. PY - 2013 DA - 2013// TI - Combined intravesical sodium hyaluronate/chondroitin sulfate therapy for interstitial cystitis/bladder pain syndrome: a prospective study JO - Ther Adv Urol VL - 5 UR - https://doi.org/10.1177/1756287213490052 DO - 10.1177/1756287213490052 ID - Giberti2013 ER - TY - JOUR AU - Damiano, R. AU - Cicione, A. PY - 2011 DA - 2011// TI - The role of sodium hyaluronate and sodium chondroitin sulphate in the management of bladder disease JO - Ther Adv Urol VL - 3 UR - https://doi.org/10.1177/1756287211418723 DO - 10.1177/1756287211418723 ID - Damiano2011 ER - TY - JOUR AU - Daniele, P. PY - 2012 DA - 2012// TI - Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis JO - Int Urogynecol J VL - 23 UR - https://doi.org/10.1007/s00192-011-1546-5 DO - 10.1007/s00192-011-1546-5 ID - Daniele2012 ER - TY - STD TI - Giannantoni A. Patient-Reported Outcomes in Bladder Pain Syndrome: Qui Auget Dolorem, Auget et Scientiam (As Pain Increases, So Increases Knowledge). Eur Urol. 2012 Feb;61(2):280-1; discussion 282-3. doi:10.1016/j.eururo.2011.10.042. Epub 2011 Nov 4. ID - ref11 ER - TY - STD TI - D’Amico AV, Whittington R, Malkowicz SB, Cote K, Loffredo M, Schultz D, et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer. 2002;95:281–6. ID - ref12 ER - TY - STD TI - RTOG http://www.rtog.org/ResearchAssociates/AdverseEventReporting.aspx. Accessed 11 January 2015 UR - http://www.rtog.org/ResearchAssociates/AdverseEventReporting.aspx ID - ref13 ER - TY - JOUR AU - Lips, I. M. AU - Dehnad, H. AU - Gils, C. H. PY - 2008 DA - 2008// TI - High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker based position verification: acute and late toxicity in 331 patients JO - Radiat Oncol VL - 3 UR - https://doi.org/10.1186/1748-717X-3-15 DO - 10.1186/1748-717X-3-15 ID - Lips2008 ER - TY - JOUR AU - Peeters, S. T. AU - Heemsbergen, W. D. AU - Putten, W. L. PY - 2005 DA - 2005// TI - Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy JO - Int J Radiat Oncol Biol Phys VL - 61 UR - https://doi.org/10.1016/j.ijrobp.2004.07.715 DO - 10.1016/j.ijrobp.2004.07.715 ID - Peeters2005 ER - TY - JOUR AU - Emami, B. AU - Lyman, J. AU - Brown, A. PY - 1991 DA - 1991// TI - Tolerance of normal tissue to therapeutic irradiation JO - Int J Radiat Oncol Biol Phys VL - 21 UR - https://doi.org/10.1016/0360-3016(91)90171-Y DO - 10.1016/0360-3016(91)90171-Y ID - Emami1991 ER - TY - JOUR AU - Fiorino, C. PY - 2009 DA - 2009// TI - Dose–volume effects for normal tissues in external radiotherapy: Pelvis. Systematic review JO - Radiother Oncol VL - 93 UR - https://doi.org/10.1016/j.radonc.2009.08.004 DO - 10.1016/j.radonc.2009.08.004 ID - Fiorino2009 ER - TY - STD TI - Costantini E, Lazzeri M, Porena M. GAGs and GAGs diseases: when pathophysiology supports the clinic. Urologia. 2013 Jul-Sep;80(3):173-8. doi: 10.5301/RU.2013.11500. Epub 2013 Sep 30. ID - ref18 ER - TY - JOUR PY - 2013 DA - 2013// TI - Increasing evidence of effectiveness of GAG therapy in different forms of cystitis JO - Eur Med J – Urol VL - 1 ID - ref19 ER - TY - JOUR AU - Fuentes-Raspall, R. AU - Inoriza, J. M. AU - Rosello-Serrano, A. AU - Auñón-Sanz, C. AU - Garcia-Martin, P. AU - Oliu-Isern, G. PY - 2013 DA - 2013// TI - Late rectal and bladder toxicity following radiation therapy for prostate cancer: predictive factors and treatment results JO - Rep Pract Oncol Radiother VL - 18 UR - https://doi.org/10.1016/j.rpor.2013.05.006 DO - 10.1016/j.rpor.2013.05.006 ID - Fuentes-Raspall2013 ER - TY - JOUR AU - Rössberger, J. AU - Fall, M. AU - Peeker, R. PY - 2005 DA - 2005// TI - Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis: discomfort, side-effects and treatment outcome JO - Scand J Urol Nephrol VL - 39 UR - https://doi.org/10.1080/00365590410018738 DO - 10.1080/00365590410018738 ID - Rössberger2005 ER - TY - JOUR AU - Madersbacher, H. AU - Ophoven, A. AU - Kerrebroeck, P. E. PY - 2013 DA - 2013// TI - GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans — a review JO - Neurourol Urodyn VL - 32 UR - https://doi.org/10.1002/nau.22256 DO - 10.1002/nau.22256 ID - Madersbacher2013 ER - TY - JOUR AU - Zelefsky, M. J. AU - Ginor, R. X. AU - Fuks, Z. PY - 1999 DA - 1999// TI - Efficacy of selective alpha-1 blocker therapy in the treatment of acute urinary symptoms during radiotherapy for localized prostate cancer JO - Int J Radiat Oncol Biol Phys VL - 45 UR - https://doi.org/10.1016/S0360-3016(99)00232-1 DO - 10.1016/S0360-3016(99)00232-1 ID - Zelefsky1999 ER -